Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$40.39M+178%-$18.98M+61.4%-$26.57M+47.0%
$9.55M+57.4%$8.19M+37.3%$6.71M+7.5%$6.28M-7.6%$6.07M-14.0%
$18.65M-5.8%$17.83M-10.4%$15.77M-14.8%$19.49M+18.5%$19.79M+45.6%
-$44.78M-$48.91M-$42.36M
$12.16M-62.8%$9.6M-68.9%$12.32M-53.2%$18.8M+6.2%$32.66M+1,333%
$74.07M$69.75M
-$5.53M+45.1%-$8.91M-54.7%-$11.04M-479%-$9.99M-744%-$10.06M-201,280%
$31.95M+390%-$2.37M+58.8%
-$56.94M-187%-$58.51M-75.3%-$54.68M-50.2%-$17.51M+47.7%-$19.87M+42.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Strata Critical Medical, Inc. Class A Common Stock generate?
Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated -$44.8M in operating cash flow over the trailing twelve months.
What is Strata Critical Medical, Inc. Class A Common Stock's free cash flow?
After $12.2M of capital expenditures, Strata Critical Medical, Inc. Class A Common Stock's free cash flow was -$56.9M over the trailing twelve months, down 186.5% year over year.
Where does Strata Critical Medical, Inc. Class A Common Stock's cash flow data come from?
Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.